Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: Mechanisms and implications

Lei Xi; Shu-Guang Zhu; Anindita Das; Qun Chen; David Durrant; Daniel C. Hobbs; Edward J. Lesnefsky; Rakesh C. Kukreja

doi:10.1016/j.niox.2012.03.006

journal article May 01, 2012

Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: Mechanisms and implications

Lei Xi

Shu-Guang Zhu Anindita Das Qun Chen

David Durrant Daniel C. Hobbs Edward J. Lesnefsky Rakesh C. Kukreja

Nitric Oxide Vol. 26 No. 4 pp. 274-284 · Elsevier BV

View at Publisher Save 10.1016/j.niox.2012.03.006

Topics

No keywords indexed for this article. Browse by subject →

References

98

[1]

Bristow "Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization" Ann. Intern. Med. (1978) 10.7326/0003-4819-88-2-168

[2]

Singal "Doxorubicin-induced cardiomyopathy" N. Engl. J. Med. (1998) 10.1056/nejm199809243391307

[3]

Swain "Congestive heart failure in patients treated with doxorubicin – a retrospective analysis of three trials" Cancer (2003) 10.1002/cncr.11407

[4]

Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

Giorgio Minotti, Pierantonio Menna, Emanuela Salvatorelli et al.

Pharmacological Reviews 2004 10.1124/pr.56.2.6

[5]

Wallace "Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis" Cardiovasc. Toxicol. (2007) 10.1007/s12012-007-0008-2

[6]

Lebrecht "Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin" J. Pathol. (2005) 10.1002/path.1863

[7]

Simunek "Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron" Pharmacol. Rep. (2009) 10.1016/s1734-1140(09)70018-0

[8]

Olson "Doxorubicin cardiotoxicity – analysis of prevailing hypotheses" FASEB J. (1990) 10.1096/fasebj.4.13.2210154

[9]

Thorn "Doxorubicin pathways: pharmacodynamics and adverse effects" Pharmacogenet. Genomics (2011) 10.1097/fpc.0b013e32833ffb56

[10]

Blanco "Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H: quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer" Cancer (2008) 10.1002/cncr.23534

[11]

Liu "Melatonin as an effective protector against doxorubicin-induced cardiotoxicity" Am. J. Physiol. Heart Circ. Physiol. (2002) 10.1152/ajpheart.01023.2001

[12]

Hasinoff "The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicin" Free Radic. Biol. Med. (2003) 10.1016/j.freeradbiomed.2003.08.005

[13]

Hasinoff "The iron chelator Dp44mT does not protect myocytes against doxorubicin" J. Inorg. Biochem. (2009) 10.1016/j.jinorgbio.2009.05.007

[14]

Zhu "Dietary nitrate supplementation protects against doxorubicin-induced cardiomyopathy by improving mitochondrial function" J. Am. Coll. Cardiol. (2011) 10.1016/j.jacc.2011.01.024

[15]

Xi "Identification of protein targets underlying dietary nitrate-induced protection against doxorubicin cardiotoxicity" J. Cell. Mol. Med. (2011) 10.1111/j.1582-4934.2011.01257.x

[16]

Fogli "The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage" FASEB J. (2004) 10.1096/fj.03-0724rev

[17]

Weinstein "Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice" J. Pharmacol. Exp. Ther. (2000) 10.1016/s0022-3565(24)39082-2

[18]

Pacher "Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction" Circulation (2003) 10.1161/01.cir.0000048192.52098.dd

[19]

Mihm "Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase" Br. J. Pharmacol. (2002) 10.1038/sj.bjp.0704495

[20]

Katori "Peroxynitrite and myocardial contractility: in vivo versus in vitro effects" Free Radic. Biol. Med. (2006) 10.1016/j.freeradbiomed.2006.08.023

[21]

Kohr "Peroxynitrite increases protein phosphatase activity and promotes the interaction of phospholamban with protein phosphatase 2a in the myocardium" Nitric Oxide (2009) 10.1016/j.niox.2009.01.003

[22]

Vasquez-Vivar "Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin" Biochemistry (1997) 10.1021/bi971475e

[23]

Deng "Differential roles of nitric oxide synthase isozymes in cardiotoxicity and mortality following chronic doxorubicin treatment in mice" Naunyn Schmiedebergs Arch. Pharmacol. (2009) 10.1007/s00210-009-0407-y

[24]

Ignarro "Nitric oxide as a unique signaling molecule in the vascular system: a historical overview" J. Physiol. Pharmacol. (2002)

[25]

O’Murchu "Increased production of nitric oxide in coronary arteries during congestive heart failure" J. Clin. Invest. (1994) 10.1172/jci116940

[26]

Bolli "Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research" J. Mol. Cell. Cardiol. (2001) 10.1006/jmcc.2001.1462

[27]

Xi "Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice" Circulation (1999) 10.1161/01.cir.99.16.2157

[28]

Guo "The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene" Proc. Natl. Acad. Sci. USA (1999) 10.1073/pnas.96.20.11507

[29]

Das "Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling" J. Biol. Chem. (2005) 10.1074/jbc.m404706200

[30]

Salloum "Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart" Circ. Res. (2003) 10.1161/01.res.0000066853.09821.98

[31]

Xi "Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia" Am. J. Physiol. Heart Circ. Physiol. (2002) 10.1152/ajpheart.00920.2001

[32]

Zhao "Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A1 receptors: evidence from gene-knockout mice" Circulation (2000) 10.1161/01.cir.102.8.902

[33]

Fisher "Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity" Circulation (2005) 10.1161/01.cir.0000160359.49478.c2

[34]

de Nigris "Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart" Eur. J. Cancer (2008) 10.1016/j.ejca.2007.12.010

[35]

Riad "Pretreatment with statin attenuates the cardiotoxicity of doxorubicin in mice" Cancer Res. (2009) 10.1158/0008-5472.can-08-3076

[36]

Atar "Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2" Am. J. Physiol. Heart Circ. Physiol. (2006) 10.1152/ajpheart.01137.2005

[37]

Ikeda "Lipophilic statins augment inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes" J. Cardiovasc. Pharmacol. (2001) 10.1097/00005344-200107000-00008

[38]

Lauer "Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action" Proc. Natl. Acad. Sci. USA (2001) 10.1073/pnas.221381098

[39]

Gladwin "Nitrite as a vascular endocrine nitric oxide reservoir that contributes to hypoxic signaling, cytoprotection, and vasodilation" Am. J. Physiol. Heart Circ. Physiol. (2006) 10.1152/ajpheart.00407.2006

[40]

Jansson "A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis" Nat. Chem. Biol. (2008) 10.1038/nchembio.92

[41]

Zweier "Enzyme-independent formation of nitric oxide in biological tissues" Nat. Med. (1995) 10.1038/nm0895-804

[42]

Lundberg "Inorganic nitrate is a possible source for systemic generation of nitric oxide" Free Radic. Biol. Med. (2004) 10.1016/j.freeradbiomed.2004.04.027

[43]

Webb "Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia–reperfusion damage" Proc. Natl. Acad. Sci. USA (2004) 10.1073/pnas.0402927101

[44]

Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation

Kenyatta Cosby, Kristine S Partovi, Jack H Crawford et al.

Nature Medicine 2003 10.1038/nm954

[45]

Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury

Nathan S. Bryan, John W. Calvert, John W. Elrod et al.

Proceedings of the National Academy of Sciences 2007 10.1073/pnas.0706579104

[46]

Duranski "Cytoprotective effects of nitrite during in vivo ischemia–reperfusion of the heart and liver" J. Clin. Invest. (2005) 10.1172/jci22493

[47]

Tsuchiya "Nitrite is an alternative source of NO in vivo" Am. J. Physiol. Heart Circ. Physiol. (2005) 10.1152/ajpheart.00525.2004

[48]

Gilchrist "Dietary nitrate – good or bad?" Nitric Oxide (2010) 10.1016/j.niox.2009.10.005

[49]

Acute Blood Pressure Lowering, Vasoprotective, and Antiplatelet Properties of Dietary Nitrate via Bioconversion to Nitrite

Andrew J. Webb, Nakul Patel, Stavros Loukogeorgakis et al.

Hypertension 2008 10.1161/hypertensionaha.107.103523

[50]

Petersson "Gastroprotective and blood pressure lowering effects of dietary nitrate are abolished by an antiseptic mouthwash" Free Radic. Biol. Med. (2009) 10.1016/j.freeradbiomed.2009.01.011

Showing 50 of 98 references

Metrics

39

Citations

98

References

Details

Published: May 01, 2012
Vol/Issue: 26(4)
Pages: 274-284
License: View

Authors

L

Lei Xi

Ph.D. Student, School of Electric Power, South China Univ. of Technology, Guangzhou, Guangdong 510641, China (corresponding author).

Institute for Technical and Macromolecular Chemistry, University of Hamburg, D-20146 Hamburg, Germany

Funding

National Institutes of Health Award: HL51045

American Heart Association Award: #0530157N

Medical Research Service, Department of Veterans Affairs

Cite This Article

Lei Xi, Shu-Guang Zhu, Anindita Das, et al. (2012). Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: Mechanisms and implications. Nitric Oxide, 26(4), 274-284. https://doi.org/10.1016/j.niox.2012.03.006

Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: Mechanisms and implications

You May Also Like